British Pharmacopoeia 2012 PDF Download

Author: British Pharmacopoeia Commission
Publisher: Stationery Office/Tso
ISBN: 9780113228690
Category : Medical
Languages : en
Pages : 1201

View

Book Description
The British Pharmacopoeia (BP) 2012 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy. The BP comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. Detailed information and guidance on various aspects of current pharmacopoeial policy and practice are provided in the Supplementary Chapters of the BP. The BP is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition package comprises a boxed six volume set containing BP in five volumes and the BP (Veterinary) volume, plus single user access to the CD-ROM and BP Online via www.pharmacopoeia.co.uk, the dedicated BP website. The online format is easy to network, allowing access for a specified number of users or across an entire organisation site.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230846
Category :
Languages : en
Pages :

View

Book Description
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230716
Category :
Languages : en
Pages :

View

Book Description
Updated annually, the BP is the official, authoritative collection of standards for UK medicinal substances for human and veterinary use. The BP 2015 includes almost 3,500 monographs. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP, making it an essential reference for students, lecturers and researchers. The online product provides subscribers with access to the British pharmacopoeia 2019, British pharmacopoeia (veterinary) 2019 and the current edition and supplements of Britsh approved names. Concurrent access to the 2014 onwards is also available

Author:
Publisher: Stationery Office Books (TSO)
ISBN: 9780113229321
Category : Reference
Languages : en
Pages : 0

View

Book Description
The British Pharmacopoeia (BP) 2013 is the authoritative, current collection of standards for UK medicinal substances and the official source of all UK pharmaceutical quality standards. It is an essential reference for anyone involved in pharmaceutical research, development, manufacture and testing, and plays a vital role in ensuring that all medicinal substances on the UK market meet standards of safety, quality and efficacy. The BP comprises monographs, which set out the mandatory standards for active substances, excipients and formulated preparations, together with supporting General Notices, Appendices (test methods, reagents, etc) and Reference Spectra. Detailed information and guidance on various aspects of current pharmacopoeial policy and practice are provided in the Supplementary Chapters of the BP. The BP is supplied in a variety of formats designed for ease of use and a wide range of applications. The hard copy edition package comprises a boxed six volume set containing BP in five volumes and the BP (Veterinary) volume, plus single user access to the CD-ROM and BP Online via www.pharmacopoeia.co.uk, the dedicated BP website. The online format is easy to network, allowing access for a specified number of users or across an entire organisation site.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113228690
Category :
Languages : en
Pages : 452

View

Book Description

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230358
Category :
Languages : en
Pages :

View

Book Description
The British Pharmacopoeia (BP) 2017 supersedes the BP 2016 and becomes legally effective on 1 January 2017. This edition incorporates new BP and European Pharmacopoeia monographs and a significant number of revised monographs. Also included is new information for unlicensed medicines and DNA barcoding. Updated annually, the BP is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. The BP 2017 includes almost 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a pharmacopoeial monograph exists, medicinal products sold or supplied in the UK must comply with the relevant monograph. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP.

Author: The Stationery Office
Publisher: Stationery Office Books (TSO)
ISBN: 9780113230204
Category : Business & Economics
Languages : en
Pages : 0

View

Book Description
Updated annually, the British Pharmacopoeia is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes almost 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012.

Author: British Pharmacopoeia Commission
Publisher:
ISBN: 9780113230891
Category :
Languages : en
Pages :

View

Book Description
Updated annually, the BP is the official, authoritative collection of standards for UK medicinal substances for human and veterinary use. The BP 2022 includes almost 4,000 monographs. All monographs and requirements of the European Pharmacopoeia are also reproduced in the BP, making it an essential reference for students, lecturers and researchers. The online product provides subscribers with access to the British pharmacopoeia 2022, British pharmacopoeia (veterinary) 2022 and the current edition and supplements of Britsh approved names. Concurrent access to the 2014 onwards is also available

Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309269393
Category : Medical
Languages : en
Pages : 377

View

Book Description
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 924156301X
Category : Medical
Languages : en
Pages : 1526

View

Book Description
The International Pharmacopoeia contains a collection of recommended methods for analysis and quality specifications for pharmaceutical substances, excipients and products. This new edition consolidates the texts of the five separate volumes of the third edition and includes new monographs for antiretroviral substances (didanosine, indinavir sulfate, nelfinavir mesilate, nevirapine, ritonavir, saquinovir, and saquinovir mesilate) adopted by the WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2004. It includes some additions and amendments to the general notices of the Pharmacopoeia, as well as some changes to its layout and format. Volume one contains monographs for pharmaceutical substances A to O and the General Notices; and volume two contains monographs for pharmaceutical substances P to Z, together with those for dosage forms and radiopharmaceutical preparations, the methods of analysis and reagents.